Evidence map›Paper›PMID 40547712›Full record

ArticleJournal of family medicine and primary care2025

Clinical and demographic characteristics of patients undergoing endovenous laser ablation for saphenous vein insufficiency.

Abdullah M Alwahbi

Abstract read
In one paragraph

Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Abdullah M AlwahbiDivision of Vascular Surgery, King Saud University for Health Sciences, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: A varicose vein is a chronic vascular condition characterized by dilated, tortuous veins with symptoms of pain, swelling, and skin changes that significantly impact the quality of life in patients suffering from this disease. The following study describes the demographic and clinical characteristics of varicose veins in patients with saphenous vein insufficiency who underwent endovenous laser ablation (EVLA). It emphasizes the main risk factors, including familial background, occupation habits, hormonal interference, and lifestyle behavior. Materials and Method: The study was Descriptive retrospective research. The studied population consisted of all patients with varicose veins who underwent EVLA in the Vascular Surgery Department from October 2015 to September 2021. Sociodemographic and clinical data on age and gender were obtained. Result: Two hundred sixty respondents were selected, primarily dominated by females at 242 (93.1%), presenting a higher prevalence among the childbearing age bracket of 25-45 years. 86.2% were classified in the C2 stage of the clinical-etiology-anatomy-pathophysiology (CEAP) classification. A total of 120 females and ten males reported long-standing or heavy physical employment. "Prominent veins" were the most frequent symptom among study participants, 102 in number (39.2%), followed by "Prominent veins and edema" among 84 participants (32.3%). Conclusion: The prevalence of varicose veins in this study was established to be higher among females aged 25-45 years. This demographic and clinical insight thus suggests that comprehensive workplace interventions, patient education, and targeted care would be prudent in the attempt to tackle lifestyle and reproductive health challenges.

Indexed as

Clinical featuresdemographic characteristicsendovenous laser ablationrisk factorssaphenous vein insufficiencyvaricose veins

Identifiers

PMID40547712
PMCPMC12178474

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.